For Quick Alerts
For Daily Alerts

Ranbaxy Laboratories tanks nearly 6% on disappointing Q3

By Religare

Shares of drug maker Ranbaxy Laboratories tumbled nearly 6 per cent in early trade on Bombay Stock Exchange (BSE) after reporting a disappointing set third quarter numbers ended September 30.

The pharma major has reported a consolidated net loss of Rs 454 crore for the third quarter ended September 2013 (Q3) due to forex loss.

Weighed down by numbers, shares of the company declined as much as 5.63 per cent to trade at Rs 363.90 a piece on the BSE.


In a similar fashion, shares of the company slipped 2.17 per cent to Rs 374.95 a piece on National Stock Exchange.

Meanwhile, the broader benchmark Sensex was quoting at 20,991.21, up 62.20 points or 0.30 per cent at 10:05 hours.

Read more about: ranbaxy laboratories
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more